Open Access

Human fetal inner ear involvement in congenital cytomegalovirus infection

  • Liliana Gabrielli1Email author,
  • Maria Paola Bonasoni2,
  • Donatella Santini3,
  • Giulia Piccirilli1,
  • Angela Chiereghin1,
  • Brunella Guerra4,
  • Maria Paola Landini1,
  • Maria Grazia Capretti5,
  • Marcello Lanari5 and
  • Tiziana Lazzarotto1
Acta Neuropathologica Communications20131:63

DOI: 10.1186/2051-5960-1-63

Received: 15 July 2013

Accepted: 23 September 2013

Published: 2 October 2013

Abstract

Background

Congenital cytomegalovirus (CMV) infection is a leading cause of sensorineural hearing loss (SNHL). The mechanisms of pathogenesis of CMV-related SNHL are still unclear. The aim is to study congenital CMV-related damage in the fetal inner ear, in order to better understand the underlying pathophysiology behind CMV-SNHL.

Results

We studied inner ears and brains of 20 human fetuses, all at 21 week gestational age, with a high viral load in the amniotic fluid, with and without ultrasound (US) brain abnormalities. We evaluated histological brain damage, inner ear infection, local inflammatory response and tissue viral load.

Immunohistochemistry revealed that CMV was positive in 14/20 brains (70%) and in the inner ears of 9/20 fetuses (45%). In the cases with inner ear infection, the marginal cell layer of the stria vascularis was always infected, followed by infection in the Reissner’s membrane. The highest tissue viral load was observed in the inner ear with infected Organ of Corti. Vestibular labyrinth showed CMV infection of sensory cells in the utricle and in the crista ampullaris.

US cerebral anomalies were detected in 6 cases, and in all those cases, the inner ear was always involved. In the other 14 cases with normal brain scan, histological brain damage was present in 8 fetuses and 3 of them presented inner ear infection.

Conclusions

CMV-infection of the marginal cell layer of the stria vascularis may alter potassium and ion circulation, dissipating the endocochlear potential with consequent SNHL. Although abnormal cerebral US is highly predictive of brain and inner ear damage, normal US findings cannot exclude them either.

Keywords

Cytomegalovirus Congenital infection Sensorineural hearing loss Inner ear Cochlea Brain damage

Background

Congenital cytomegalovirus (CMV) infection is a leading cause of sensorineural hearing loss (SNHL), occurring in 30-65% of children symptomatic at birth and in 7-15% of children with asymptomatic infection [1, 2]. SNHL may be present at birth or with a late onset, after months or even years [3, 4]. It can be unilateral or bilateral, with a wide range of severity and progression [5, 6]. Approximately half of hearing losses due to congenital CMV infection are late-onset or progressive [7].

The mechanisms of pathogenesis of CMV-related SNHL are still unclear. Animal models have been studied to find CMV target cells in the inner ear and the role of associated inflammatory infiltrate [810]. The paucity of temporal bone autopsy specimens from infants with congenital CMV infection has hindered the critical correlation of histopathology with pathogenesis. Histopathology of SNHL was previously examined in a small number of human inner ears of fetuses at different gestational ages with abnormal brain ultrasound (US) findings [11]. The main finding was that CMV infection of the structures involved in endolymph production may cause potassium imbalance and subsequent degeneration of the sensory structures. However, further studies are necessary to explain the multiple factors involved in CMV-related SNHL.

We studied a wide autopsy series of fetal human inner ears all at 21 weeks of gestation, with and without US brain abnormalities and with a high viral load in the amniotic fluid. We examined histological brain damage, inner ear infection, local inflammatory response, and tissue viral load. The aim of our study is to further develop information about congenital CMV-related damage in the inner ear, especially cochlear infection, in order to better understand the underlying pathophysiology behind CMV-SNHL.

Methods

Subjects

Both inner ears and brains of 20 fetuses with congenital CMV infection documented at 21 weeks gestation were submitted for histological examination.

All the fetuses were from pregnant women with primary CMV infection arising before the 12th week of gestation. Women who had anti-CMV IgM and anti-CMV IgG of low avidity or who seroconverted to CMV IgG positivity were classified as having primary infection. Fetal diagnosis of CMV infection was based on CMV positivity in amniotic fluid by culture and by Real Time polymerase chain reaction (PCR) at 21 weeks gestation. The viral load was more than 105 copies/ml in all amniotic fluids.

At the time of amniocentesis, all pregnant women underwent US examinations that included a survey of all fetal organs [12]. Given the particular neurotropism of CMV, the intracranial anatomy was evaluated by targeted transvaginal neurosonographic examination, when permitted by the low position of the fetal head [13].

We studied 6 fetuses at 21 weeks gestation from CMV-seronegative women as negative controls. One case was a spontaneous miscarriage due to cervical incompetence and the other cases were elective terminations of pregnancy due to cardiac malformations (3 cases) and Spina bifida (2 cases).

The fetal tissues were analysed after obtaining the informed consent of the parents and in accordance with the policies of the Ethical Committee of St. Orsola-Malpighi General Hospital, Bologna, Italy and regulations of the Italian Ministry of Health, Rome, Italy.

Histological examinations

The brain and both fetal inner ears were submitted for histological and immunohistochemical studies. Fetal inner ears were carefully removed from the temporal bone, left in a weak decalcifier (fixative Gooding Stewart, containing formaldehyde, Bio-Optica, Milano, Italy) for 24–36 hours, and then tangentially sectioned along the insertion of the VIII nerve.

Immunohistochemical staining for CMV early (ppUL44) antigen was performed to identify CMV-positive cells.

Brain damage was classified as severe, moderate and mild according to a score which considered and summarized each single lesion and the severity of the inflammatory infiltrate [14, 15]. Severe damage included polymicrogyria, cortical necrosis, periventricular leukomalacia and microglial nodules. Moderate damage included telencephalic leukencephalopathy, microglial nodules and focal necrosis. Mild damage included telencephalic leukencephalopathy and rare microglial nodules.

The inflammatory infiltrate (B and T lymphocytes) was studied by immunohistochemical staining for CD3, CD4, CD8, CD20. Granzyme B expression was investigated as a marker of cytotoxic activation of immune effector cells.

The inflammatory infiltrate was scored semi-quantitatively to assess the density of CD8 T-lymphocytes in the different ear structures, similar to what was used in the brain [14]. The quantity was defined as: score 0: no lymphocytes detected; score 1: scanty; score 2: numerous; score 3: abundant. Another score was added according to the distribution of lymphocytes, such as: score 1: scattered lymphocytes; score 2: scattered lymphocytes and clusters. As a marker of activation, granzyme B was graded as a percentage of the immune effector cells observed: score 0: no activated cells; score 1: 1–10%; score 2: 11–25%; score 3; 26–50%; and score 4: > = 51%.

As a whole, the inflammatory response was evaluated by adding the three scores to each inner ear structure examined. The final score ranged from 0 to 9. A mild inflammatory response was between 1 and 3, a moderate response between 4 and 6, and a severe response between 7 and 9.

The following antibodies were used: anti-CMV (DDG9/CCH2, monoclonal mouse, diluition 1:80) obtained from DAKO (Glostrup, Denmark); anti-CD3 (2GV6, monoclonal rabbit, prediluited), anti-CD4 (SP35, monoclonal rabbit, prediluited), anti CD-8 (SP57, monoclonal rabbit, prediluited), anti-CD20 (L26, monoclonal rabbit, prediluited), anti-granzyme B (GrB7, polyclonal, prediluited) from Roche Diagnostics (Tucson, Arizona, USA).

Virological examinations

The shell vial procedure was used for CMV isolation from amniotic fluid as described elsewhere [16]. DNA was extracted from 1 ml of amniotic fluid using the NucliSens easyMAG System (bioMerieux, Marcy l’Etoile, France), eluted in 25 μl of Elution Buffer and 20 μl were processed for CMV DNA quantification. DNA extraction from paraffin-embedded tissue was performed on 10 micron tissue slices using BioSprint 15 DNA Blood Kit (Qiagen GmbH, Hilden, Germany). Purified DNA was eluted in 80 μl of distilled water and quantified using Real-Time PCR assays (Quantifiler Human DNA Quantification Kit, Applied Biosystems, Foster City, California, USA). Five ng of DNA were processed for CMV DNA quantification.

CMV DNA was quantified using a Real-Time PCR assay (CMV ELITe MGB™ kit, ELITech Group, Trezzano, Milano, Italy). Amplification, detection and analysis were performed using the ABI PRISM 7300 platform (Applied Biosystems, Foster City, California, United States). The limit of detection for amniotic fluid was 16 copies/ml and viral load was reported as number of copies/ml. The limit of detection for tissue samples was 13 copies/5 ng of DNA and viral load was reported as number of copies/5 ng of DNA.

Results

Immunohistochemistry for CMV early antigen performed on brains of 20 congenitally infected fetuses revealed that CMV was positive in 14 brains (70%) (Table 1).
Table 1

Virological, ultrasound and histological findings in 20 fetuses studied

Case n°

Ultrasound findings

CMV immunohistochemistry

Histological brain damage

  

Brain

Inner ear

 

1

Cerebral periventricular hyperechogenicity

P

P

severe

2

Cerebral periventricular hyperechogenicity, growth retardation, hyperechogenic bowel

P

P

severe

3

Cerebral ventriculomegaly, cerebral periventricular hyperechogenicity, hyperechogenic bowel

P

P

severe

4

Cerebral periventricular hyperechogenicity

P

P

moderate

5

Cerebral periventricular hyperechogenicity

P

P

moderate

6

Cerebral periventricular hyperechogenicity, hyperechogenic bowel

P

P

moderate

7

Normal

P

P

moderate

8

Normal

P

P

moderate

9

Normal

P

P

moderate

10

Normal

P

N

severe

11

Normal

P

N

moderate

12

Normal

P

N

moderate

13

Normal

P

N

moderate

14

Normal

P

N

mild

15

Normal

N

N

not present

16

Normal

N

N

not present

17

Normal

N

N

not present

18

Normal

N

N

not present

19

Normal

N

N

not present

20

Normal

N

N

not present

P positive; N negative.

Among 14 CMV-positive brains, 4 cases showed severe histological damage (29%), 9 cases showed moderate damage (64%) and 1 case showed mild damage (7%) (Table 1).

We found no evidence of brain CMV infection by immunohistochemistry in 6 out of the 20 fetuses studied (30%). No histological damage was observed in these 6 fetuses lacking evidence of brain infection (Table 1).

In all the 20 fetuses studied, CMV-positive cells were detected in all placentas and in at least one organ including pancreas, lungs, kidneys and liver; thus confirming congenital CMV infection.

At 21 weeks gestation, abnormal cerebral US findings were observed in 6 out of 20 fetuses (30%). At histology, brain damage was present in all of them; severe damage in 3 fetuses and moderate damage in 3 (Table 1).

Among the 14 fetuses with normal US in the brain and in the other organs, in 8 cases the brain was CMV-positive (57%) with a brain damage that was severe in 1 case, moderate in 6 and mild in one. The remaining 6 fetuses with normal US showed CMV-negative brain and no histological damage (43%) (Table 1).

Immunohistochemistry for CMV early antigen performed on both inner ears of the 20 fetuses revealed that CMV was positive in 9 fetuses (45%) (Table 1).

The inner ears were positive only in fetuses with CMV-positive brains.

Among the 9 fetuses with CMV-positive inner ears, 6 showed bilateral CMV-positivity. In 2 fetuses, only one inner ear was infected. In another fetus, only the left inner ear was available (Table 2). Therefore, the total number of CMV-positive inner ears was 15. Histological examination revealed that many structures were involved (Table 2).
Table 2

CMV-antigen and CD8 T-lymphocytes in the cochlea and in the vestibular apparatus in 9 fetuses with CMV-positive inner ear

Case n°

Cochlea

Vestibular apparatus

 

Organ of Corti

Stria vascularis

Reissner’s membrane

Spiral ganglion

Cochlear nerve

Crista ampullaris

Semicircular canals

Saccule

Utricule

Vestibular ganglion

1

R

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

L

N/+

P/++

N/+

N/++

N/+

N/+

N/+

N/+

P/+

N/++

2

R

N/+

P/++

N/+

P/+

N/+

N/+

N/+

N/+

P/++

N/+

L

P/+

P/+++

P/++

P/+

N/+

N/+

N/+

N/+

N/+

N/+

3

R

N/-

P/+

N/-

N/-

N/-

N/-

N/-

N/-

N/-

N/-

L

N/-

P/+

P/-

N/+

N/-

P/+

P/+

N/-

P/+

N/-

4

R

N/+

P/++

N/++

N/+

N/+

N/+

N/-

N/+

P/+

N/+

L

N/-

N/+

N/-

N/-

N/-

N/-

N/-

N/-

N/-

N/+

5

R

N/+

P/+++

P/++

N/+

N/+

P/+

N/+

N/++

N/++

P/+

L

N/+

P/+++

P/+

N/+

N/+

P/++

N/+

N/++

N/++

P/+

6

R

N/+

P/+

P/+

N/+

N/+

N/-

N/-

N/-

N/-

N/-

L

N/-

P/+

P/+

N/-

N/-

N/-

N/-

N/-

P/+

N/-

7

R

N/-

P/+

N/-

N/+

N/+

N/+

N/-

N/+

N/+

N/+

L

N/+

P/++

N/+

N/+

N/+

N/-

N/-

N/-

N/-

N/+

8

R

N/-

P/+

N/-

N/+

N/+

N/+

N/-

N/+

N/+

N/+

L

N/-

N/+

N/-

N/-

N/-

N/-

N/-

N/-

N/-

N/+

9

R

N/-

P/++

N/+

N/+

N/+

N/+

N/-

P/++

N/-

N/+

 

L

N/+

P/++

P/+

N/+

N/+

N/+

N/-

P/+

N/+

N/+

NA not available; R right; L left; P CMV-positive; N CMV-negative; - no CD8 T-lymphocytes; + scanty CD8 T-lymphocytes; ++ numerous CD8 T-lymphocytes; +++ abundant CD8 T-lymphocytes.

Regarding the cochlea, the superficial marginal layer of the stria vascularis was always CMV-positive (15 inners ears) (Figure 1A). The Reissner’s membrane was often infected (7 inner ears) (Figure 1B), whereas the Organ of Corti was found to be CMV-positive only in one fetus, in the left side (Figure 1C). In the same fetus, the spiral ganglion was infected, bilaterally (Figure 1D).
Figure 1

CMV infection in the cochlea. A) Numerous cytomegalic inclusions in the marginal layer of the stria vascularis (arrow). Haematoxylin and eosin (HE). B) Cytomegalic inclusions in the marginal layer of the stria vascularis (small arrow) and in the Reissner’s membrane (big arrow). HE. C) CMV immunohistochemistry showing strong nuclear CMV positivity in the marginal cell layer (big arrow) and in the Organ of Corti (small arrow). In the Organ of Corti, CMV-positive cells are most likely one ciliated cell (top) and one supporting cell (bottom). The other CMV-positive cell on the right is probably a supporting cell. D) Spiral ganglion: a cytomegalic neuron surrounded by lymphocytes. HE.

Regarding the vestibular apparatus, utricule hair cells were found positive unilaterally in five fetuses (Figure 2A). In two fetuses, CMV-positive cells were observed in the sensory cells of the ampullary crest (Figure 2B). In one of them, the vestibular ganglion was infected (Figure 2C). In the other fetus, together with the ampullary crest, the contiguous semicircular canal showed CMV-positive cells (Figure 2D).
Figure 2

CMV infection in the vestibular apparatus. A) CMV immunohistochemistry showing CMV-positive cells within the utricle. The cell indicated by the arrow may likely be a sensory cell as suggested by the presence of cilia. B) Crista ampullaris: cytomegalic cells in the superficial epithelial layer. HE. C) Vestibular ganglion: a cluster of lymphocytes surrounding infected neurons (arrow). HE. D) One cytomegalic cell (arrow) in the epithelial layer of a semicircular canal. HE. E) Saccule: cytomegalic inclusion (arrow) in the membranous layer. On the bottom, there is the sensory macula with the otolith layer, strongly basophilic, and the hair cells underneath. HE. F) Saccule: cytomegalic cells within the macula. The positive cells may be a supporting cell (left) and a sensory cell (right). CMV immunohistochemistry.

In one fetus, CMV-positive cells were observed bilaterally in the saccule, in the membranous layer and in the sensory cells of the macula (Figure 2E, F).

In control fetuses, brain and inner ears were always CMV-negative by immunohistochemistry.

The inflammatory infiltrate, mainly composed of activated CD8 T-lymphocytes, Granzyme B-positive, was mostly found close to CMV-positive cells (Figure 3A, B). CD-8 T-lymphocytes, especially in clusters, were more abundant in the inner ear structures where the virus was detected (Table 2). No CD4 T-lymphocytes and CD20 B-lymphocytes were observed.
Figure 3

Fetal inflammatory response in CMV-positive inner ears. A) CD8 immunohistochemistry showing numerous CD8-positive lymphocytes in the epithelial layers of the stria vascularis and within the Reissner’s membrane. Lymphocytic infiltrate was mainly found in proximity to cytomegalic cells. B) Granzyme B immunohistochemistry in the stria vascularis: most of the lymphocytes close to CMV infected cells (small arrows) were activated expressing Granzyme B (big arrow). C) CD8 immunohistochemistry showing CD8-positive lymphocytes along the cochlear nerve fibers. D) CD8 immunohistochemistry showing CD8-positive lymphocytes within the spiral ganglion.

CD8 T-lymphocytes were also found along cochlear nerve fibers and in the spiral ganglion (Figure 3C, D). In the cochlear nerve, with no CMV-positive cells, the lymphocytes were not activated. In the spiral ganglion, CD8 T-lymphocytes, Granzyme B-positive, were always observed adjacent and near cytomegalic cells. There were also non-activated lymphocytes, more scattered and less associated with infected cells.

In the 15 CMV-positive inner ears, Real Time PCR detected a viral load between 13 and 2125 copies/5 ng DNA. The highest was observed in the inner ear with infected Organ of Corti (Figure 4). Among the CMV-negative inner ears and negative controls, Real Time PCR did not detect viral DNA.
Figure 4

Tissue viral load in the 15 CMV-positive inner ears.

Discussion

The inner ear contains the organ of hearing, the cochlea and the organ of balance, the vestibular labyrinth (Figure 5). The inner ear functions are briefly reviewed below in order to understand potential CMV damage.
Figure 5

Human fetal cochlea at 21 weeks gestation. A) Cochlear turn: the cochlea is divided in three tubular compartments: scala vestibuli, tympani and media (detail). The first two contain perilymph, a liquid with an ionic composition similar to extracellular fluids. The scala media contains endolymph, with a positive potential of 80 mV, the endocochlear potential, essential for stimulating the sensory cells of the Organ of Corti. The signals generated travel along the cochlear nerve fibers (arrow) to the spiral ganglion (star) and then through the auditory pathway. B) Scala media: the scala media contains the Organ of Corti (OC), composed of sensory cells innervated by the cochlear nerve (CN) and stimulated by the tectorial membrane (TM) according to endolymph waves. Endocochlear potential within the scala media is mainly maintained by the stria vascularis (SV) with the contribution of the Reissner’s membrane (RM).

The cochlea is a snail-shaped structure divided in three tubular compartments: the scala media, the scala tympani and the scala vestibuli. The scala tympani and vestibuli contain perilymph whose ionic composition is high in sodium and low in potassium. The scala media contains endolymph, high in potassium and low in sodium and calcium, which has a positive potential of +80 mV, the endocochlear potential [17, 18]. Endocochlear potential positivity is maintained by potassium recycling, through many ion channels mainly regulated by the stria vascularis, composed of three layers of epithelial cells: the marginal towards the scala media, the intermediate and the basal. Between the intermediate and marginal cells there is the intrastrial space isolated from perilymph and endolymph, containing a fluid low in potassium and with a positive potential of +90 mV. Isolation of intrastrial space maintains the endocochlear potential and allows potassium diffusion [17, 1923].

Potassium activates the hair cells of the organ of Corti involved in mechano-transduction of sound waves, which projects to the spiral ganglion and, through the VIII (cochlear) nerve, to the cochlear nuclei in the brainstem [2428].

The vestibular apparatus, responsible for the detection and maintenance of the equilibrium, is composed of the utricle, the saccule and the three semicircular canals. Signal mechano-transduction is regulated by the hair cells, located in the macula (utricle and saccule) and in the ampulla (semicircular canals). In both hair cell cilia are embedded in a gelatinous material, the otolithic membrane and the cupula, whose movements open or close different ion channels [2931]. Dark cells are secretory cells located in the utricle and at the base of ampullae, which are absent in the saccule. They function in a similar way to the marginal cells of the stria vascularis, regulating potassium circulation and the endovestibular potential, which is +/−1 mV [32]. Hair cells take synapse with the vestibular nerve fibers that project to the vestibular ganglion, the first step of the vestibular pathway [33, 34].

CMV- related damage

As summarized and simplified above, the inner ear is a highly complex structure with delicate mechanisms and integrated neural connections. This being said, the functionality of the inner ear may be altered by CMV infection at many different levels with superimposed effects. Although the final result is mainly NSHL, little is known about cell-infection and damage with consequent altered physiology. Analysing the type of cell and the structures infected by CMV, the most likely pathophysiological events may be at least speculated.

The cochlea

Considering our immunohistochemical results, the stria vascularis was found to be always CMV-positive in the marginal cell layer. As already mentioned, these cells are fundamental in keeping the endocochlear potential positive through potassium recycling. CMV-infection may alter the delicate ion circulation throughout the stria vascularis, damaging the ion channels and dissipating the positive potential of the intrastrial space. Absent or altered potassium channels, as reported in animal models or in genetic diseases, are responsible of hearing loss [23, 35]. However, whatever affects endocochlear potential formation may potentially result in SNHL. For example, abnormal homeostasis of other ions, chloride and sodium, or gap junctions damage [36, 37]. Without the endocochlear potential, the hair cells of the Organ of Corti may degenerate due to excessive calcium concentration in the endolymph or they may not simply be activated due to the lack of further signal transmission [32].

CMV-positive cells were also often observed in the Reissner’s membrane. This may result in electro-chemical imbalance between endolymph and perilymph. CMV-infection may also damage sodium and chloride channels, which contribute to endocochlear potential.

CMV-positive cells in the Organ of Corti were detected only in one fetus (case number 2), unilaterally. Two were supporting cells, though one is a ciliated cell corresponding to an inner hair cell (Figure 1C). Supporting cells play a role in survival of hair cells and spiral ganglion neurons. While in some species hair cell may regenerate, this event does not happen in mammals [3840].

CMV infection in the hair cells may impair their functionality, altering the kinetic of stereocilia, cytoskeleton and in the outer hair cell, prestin contractility [4143].

Regarding the aforementioned case with CMV-positive Organ of Corti, positive-cells were also observed in the spiral ganglion, bilaterally. Also neurons of the spiral ganglion cannot be replaced.

Moreover, in this inner ear the highest CMV-load was detected. Therefore, these findings suggest that this fetus, at birth, may have been hearing impaired.

Severity of inflammatory infiltrate, T-CD8 activated lymphocytes, must be taken into account as a contributory factor to hair cell damage, either directly, destroying infected cells, or indirectly, through cytokine secretion. Inflammatory mediators, as seen in prolonged infection, may also affect the other components of the scala media, such as the spiral ligament, inducing fibrosis [810]. Lymphocytes within the cochlear nerve, and spiral ganglia may also affect nerve conduction and integrity of the auditory pathway.

Non-activated CD8 T-lymphocytes were present along the cochlear nerve fibers and in the spiral ganglion, not in association with CMV-positive cells. Their presence probably reflects an extensive and ongoing inflammatory process with lymphocyte recruiting.

The vestibular labyrinth

In our group of fetuses, the vestibular apparatus showed less structures infected by CMV compared to the cochlea. The utricule, with infected hair cells of the macula, was the most involved with five cases. In two cases, the sensory cells of the crista ampullaris showed CMV-infection. The saccule was bilaterally found only in one case, involving the sensory hair cells and the epithelial cells of the membranous layer. The semicircular canals were the least infected with only one case, unilaterally. These findings differ from what has been observed in the past, in which sensory cells of the macula and the crista ampullaris were always spared, instead affecting supporting cells and dark cells [11, 44]. As already mentioned, dark cells play a part in the formation of the endovestibular potential, regulating potassium secretion, and their damage may further contribute to SNHL [32].

Furthermore, vestibular CMV infection may be a rare cause of delayed endolymphatic hydrops, which consists of development of hydropic otologic symptoms in the setting of prolonged deafness [45].

Although these findings suggest that CMV may be involved in vestibular functionality, newborns with congenital CMV infection are not routinely tested since CMV is not considered to play a significant role in vestibular pathway alteration. It should be noted however that some authors have reported abnormal vestibular tests in congenital infected babies [44, 46, 47].

Inner ear and brain damage

US brain abnormalities at 21 weeks gestation were detected in six fetuses (30%), and in all these cases the brain revealed a histological damage and the inner ear was CMV-positive. This confirms that the inner ear is often involved in severely infected babies.

US has a sensibility in predicting histological brain damage, in case of high viral load in amniotic fluid, of 43% (6/14) and in predicting CMV-positive in inner ears of 67% (6/9).

In the cases of normal US findings, we observed a histological brain damage in eight fetuses (57%) and a CMV-positive inner ear in three fetuses (21%). Therefore a normal US cannot exclude brain or inner ear infection.

Conclusion

The present study investigated the brain and the inner ear of 20 fetuses from women primarily infected by CMV before 12 weeks gestation and with a positive prenatal diagnosis. This study confirms the findings of a previous paper [11] and support the pathophysiological mechanisms suggested. However, we examined a larger number of fetuses and our series had the same characteristics: maternal primary infection during the first week of pregnancy, high viral load in the amniotic fluid and histology studies performed in fetuses at the same gestational week (21 weeks).

In the cases with inner ear infection, the marginal cell layer of the stria vascularis was always infected, followed by infection in the Reissner’s membrane. This infection may affect endocochlear potential formation and ion homeostasis, especially potassium recycling.

Vestibular labyrinth also showed CMV infection in sensory cells in the utricle as well as in the crista ampullaris. The clinical consequence of these findings are still unknown even though some authors have reported the possibility of carrying out vestibular tests in congenital infected babies [44, 46, 47].

Moreover, CMV Real Time revealed a correlation between tissue viral load and the number of inner ear structures with tissue damage and inflammatory infiltrate.

Inner ear CMV infection was also correlated with cerebral US and histological findings. All the cases with abnormal brain US findings revealed histological inner ear infection. However, a normal brain scan alone cannot exclude brain and inner ear damage.

Abbreviations

CMV: 

Cytomegalovirus

SNHL: 

Sensorineural hearing loss

US: 

Ultrasound

PCR: 

Polymerase chain reaction.

Declarations

Acknowledgments

This work was supported by grants (SA43GABR) from St Orsola-Malpighi University Hospital Bologna, as the prize for winning a hospital competition for the presentation of scientific research projects.

Authors’ Affiliations

(1)
Operative Unit of Clinical Microbiology, St. Orsola-Malpighi General Hospital, University of Bologna
(2)
Operative Unit of Pathology, St. Maria Nuova Hospital
(3)
Operative Unit of Pathology, St. Orsola-Malpighi General Hospital, University of Bologna
(4)
Operative Unit of Obstetrics and Prenatal Medicine, St. Orsola-Malpighi General Hospital, University of Bologna
(5)
Operative Unit of Neonatology, St. Orsola-Malpighi General Hospital, University of Bologna

References

  1. Cheeran MC, Lokensgard JR, Schleiss MR: Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009, 22: 99–126. 10.1128/CMR.00023-08PubMed CentralView ArticlePubMedGoogle Scholar
  2. Fowler KB, Boppana SB: Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 2006, 35: 226–231. 10.1016/j.jcv.2005.09.016View ArticlePubMedGoogle Scholar
  3. Grosse SD, Ross DS, Dollard SC: Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008, 41: 57–62. 10.1016/j.jcv.2007.09.004View ArticlePubMedGoogle Scholar
  4. Rosenthal LS, Fowler KB, Boppana SB, Britt WJ, Pass RF, Schmid SD, Stagno S, Cannon MJ: Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J 2009, 28: 515–520. 10.1097/INF.0b013e318198c724PubMed CentralView ArticlePubMedGoogle Scholar
  5. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF: Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000, 11: 283–290.PubMedGoogle Scholar
  6. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997, 130: 624–630. 10.1016/S0022-3476(97)70248-8View ArticlePubMedGoogle Scholar
  7. Fowler KB, Dahle AJ, Boppana SB, Pass RF: Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999, 135: 60–64. 10.1016/S0022-3476(99)70328-8View ArticlePubMedGoogle Scholar
  8. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR: Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol 2011, 17: 201–211. 10.1007/s13365-011-0024-7PubMed CentralView ArticlePubMedGoogle Scholar
  9. Schraff SA, Schleiss MR, Brown DK, Meinzen-Derr J, Choi KY, Greinwald JH, Choo DI: Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury. Otolaryngol Head Neck Surg 2007, 137: 612–618. 10.1016/j.otohns.2007.03.044View ArticlePubMedGoogle Scholar
  10. Yuehua Q, Longzhen Z, Kailin X, Lingyu Z, Lingjian M, Jun W, Hong M: Inflammatory lesions of cochlea in murine cytomegalovirus-infected mice with hearing loss. Cell Biochem Biophys 2012, 62: 281–287. 10.1007/s12013-011-9292-3View ArticlePubMedGoogle Scholar
  11. Teissier N, Delezoide AL, Mas AE, Khung-Savatovsky S, Bessières B, Nardelli J, Vauloup-Fellous C, Picone O, Houhou N, Oury JF, Van Den Abbeele T, Gressens P, Adle-Biassette H: Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol 2011, 122: 763–774. 10.1007/s00401-011-0895-yView ArticlePubMedGoogle Scholar
  12. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N: Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008, 198: 1–7. 10.1016/j.ajog.2007.11.031View ArticleGoogle Scholar
  13. Simonazzi G, Guerra B, Bonasoni P, Pilu G, Lazzarotto T, Santini D, Rizzo N: Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. Am J Obstet Gynecol 2010, 202: 1–5. 10.1016/j.ajog.2009.08.028View ArticleGoogle Scholar
  14. Gabrielli L, Bonasoni MP, Santini D, Piccirilli G, Chiereghin A, Petrisli E, Dolcetti R, Guerra B, Piccioli M, Lanari M, Landini MP, Lazzarotto T: Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect 2012, 18: 419–427. 10.1111/j.1469-0691.2012.03983.xView ArticleGoogle Scholar
  15. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA: Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32: 321–329. 10.1002/ana.410320304View ArticlePubMedGoogle Scholar
  16. Lazzarotto T, Gabrielli L, Foschini MP, Lanari M, Guerra B, Eusebi V, Landini MP: Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003, 112: 153–157. 10.1542/peds.112.2.e153View ArticleGoogle Scholar
  17. Hibino H, Nin F, Tsuzuki C, Kurachi Y: How is the highly positive endocochlear potential formed? the specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch 2010, 459: 521–533. 10.1007/s00424-009-0754-zView ArticlePubMedGoogle Scholar
  18. Kurt S, Sausbier M, Rüttiger L, Brandt N, Moeller CK, Kindler J, Sausbier U, Zimmermann U, van Straaten H, Neuhuber W, Engel J, Knipper M, Ruth P, Schulze H: Critical role for cochlear hair cell BK channels for coding the temporal structure and dynamic range of auditory information for central auditory processing. FASEB J 2012, 26: 3834–3843. 10.1096/fj.11-200535PubMed CentralView ArticlePubMedGoogle Scholar
  19. Fahlke C, Fischer M: Physiology and pathophysiology of ClC-K/barttin channels. Front Physiol 2010, 1: 155.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Kim KX, Marcus DC: Inward-rectifier chloride currents in Reissner’s membrane epithelial cells. Biochem Biophys Res Commun 2010, 394: 434–438. 10.1016/j.bbrc.2010.03.048PubMed CentralView ArticlePubMedGoogle Scholar
  21. Kim SH, Marcus DC: Regulation of sodium transport in the inner ear. Hear Res 2011, 280: 21–29. 10.1016/j.heares.2011.05.003PubMed CentralView ArticlePubMedGoogle Scholar
  22. Yamazaki M, Kim KX, Marcus DC: Sodium selectivity of Reissner’s membrane epithelial cells. BMC Physiol 2011, 11: 4. 10.1186/1472-6793-11-4PubMed CentralView ArticlePubMedGoogle Scholar
  23. Zdebik AA, Wangemann P, Jentsch TJ: Potassium ion movement in the inner ear: insights from genetic disease and mouse models. Physiology (Bethesda) 2009, 24: 307–316. 10.1152/physiol.00018.2009View ArticleGoogle Scholar
  24. Giacomello M, De Mario A, Primerano S, Brini M, Carafoli E: Hair cells, plasma membrane Ca 2 ATPase and deafness. Int J Biochem Cell Biol 2012, 44: 679–683. 10.1016/j.biocel.2012.02.006View ArticlePubMedGoogle Scholar
  25. Nam JH, Fettiplace R: Optimal electrical properties of outer hair cells ensure cochlear amplification. PLoS One 2012, 7: 50572. 10.1371/journal.pone.0050572View ArticleGoogle Scholar
  26. Appler JM, Goodrich LV: Connecting the ear to the brain: molecular mechanisms of auditory circuit assembly. Prog Neurobiol 2011, 93: 488–508. 10.1016/j.pneurobio.2011.01.004PubMed CentralView ArticlePubMedGoogle Scholar
  27. Bulankina AV, Moser T: Neural circuit development in the mammalian cochlea. Physiology (Bethesda) 2012, 27: 100–112. 10.1152/physiol.00036.2011View ArticleGoogle Scholar
  28. Nayagam BA, Muniak MA, Ryugo DK: The spiral ganglion: connecting the peripheral and central auditory systems. Hear Res 2011, 278: 2–20. 10.1016/j.heares.2011.04.003PubMed CentralView ArticlePubMedGoogle Scholar
  29. Levin ME, Holt JR: The function and molecular identity of inward rectifier channels in vestibular hair cells of the mouse inner ear. J Neurophysiol 2012, 108: 175–186. 10.1152/jn.00098.2012PubMed CentralView ArticlePubMedGoogle Scholar
  30. Lysakowski A, Gaboyard-Niay S, Calin-Jageman I, Chatlani S, Price SD, Eatock RA: Molecular microdomains in a sensory terminal, the vestibular calyx ending. J Neurosci 2011, 31: 10101–10114. 10.1523/JNEUROSCI.0521-11.2011PubMed CentralView ArticlePubMedGoogle Scholar
  31. Schubert MC, Minor LB: Vestibulo-ocular physiology underlying vestibular hypofunction. Phys Ther 2004, 84: 373–385.PubMedGoogle Scholar
  32. Ciuman RR: Stria vascularis and vestibular dark cells: characterization of main structures responsible for inner-ear homeostasis, and their pathophysiological relations. J Laryngol Otol 2009, 123: 151–162. 10.1017/S0022215108002624View ArticlePubMedGoogle Scholar
  33. Highstein SM, Holstein GR: The anatomy of the vestibular nuclei. Prog Brain Res 2006, 151: 157–203.View ArticlePubMedGoogle Scholar
  34. Uchino Y, Kushiro K: Differences between otolith- and semicircular canal-activated neural circuitry in the vestibular system. Neurosci Res 2011, 71: 315–327. 10.1016/j.neures.2011.09.001View ArticlePubMedGoogle Scholar
  35. Marcus DC, Wu T, Wangemann P, Kofuji P: KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 2002, 282: 403–407. 10.1152/ajpcell.00312.2001View ArticleGoogle Scholar
  36. Macarthur CJ, Hausman F, Kempton JB, Sautter N, Trune DR: Inner ear tissue remodeling and ion homeostasis gene alteration in murine chronic otitis media. Otol Neurotol 2013, 34: 338–346. 10.1097/MAO.0b013e31827b4d0aPubMed CentralView ArticlePubMedGoogle Scholar
  37. Rodriguez-Paris J, Pique L, Colen T, Roberson J, Gardner P, Schrijver I: Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assessment of its diagnostic value for medical practice. PLoS One 2010, 5: 11804. 10.1371/journal.pone.0011804View ArticleGoogle Scholar
  38. Burns JC, Corwin JT: A historical to present-day account of efforts to answer the question, “what puts the brakes on mammalian hair cell regeneration?”. Hear Res 2013, 297: 52–67.PubMed CentralView ArticlePubMedGoogle Scholar
  39. Monzack EL, Cunningham LL: Lead roles for supporting actors: critical functions of inner ear supporting cells. Hear Res 2013, 303: 20–29.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Rubel EW, Furrer SA, Stone JS: A brief history of hair cell regeneration research and speculations on the future. Hear Res 2013, 297: 42–51.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Homma K, Duan C, Zheng J, Cheatham MA, Dallos P: The V499G/Y501H mutation impairs prestin’s fast motor kinetics and has significance for defining functional independence of individual prestin subunits. J Biol Chem 2012, 288: 2452–2463.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Nin F, Reichenbach T, Fisher JA, Hudspeth AJ: Contribution of active hair-bundle motility to nonlinear amplification in the mammalian cochlea. Proc Natl Acad Sci U S A 2012, 109: 21076–21080. 10.1073/pnas.1219379110PubMed CentralView ArticlePubMedGoogle Scholar
  43. Worman HJ, Segil N: Nucleocytoplasmic connections and deafness. J Clin Invest 2013, 123: 553–555.PubMed CentralPubMedGoogle Scholar
  44. Strauss M: A clinical pathologic study of hearing loss in congenital cytomegalovirus infection. Laryngoscope 1985, 95: 951–962.PubMedGoogle Scholar
  45. Huygen PL, Admiraal RJ: Audiovestibular sequelae of congenital cytomegalovirus infection in 3 children presumably representing 3 symptomatically different types of delayed endolymphatic hydrops. Int J Pediatr Otorhinolaryngol 1996, 35: 143–154. 10.1016/0165-5876(96)83899-7View ArticlePubMedGoogle Scholar
  46. Strauss M: Human cytomegalovirus labyrinthitis. Am J Otolaryngol 1990, 11: 292–298. 10.1016/0196-0709(90)90057-3View ArticlePubMedGoogle Scholar
  47. Zagólski O: Vestibular-evoked myogenic potentials and caloric stimulation in infants with congenital cytomegalovirus infection. J Laryngol Otol 2008, 122: 574–579.View ArticlePubMedGoogle Scholar

Copyright

© Gabrielli et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement